Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ)

Historical Holders from Q3 2021 to Q2 2025

Symbol
OMGAQ
Type / Class
Equity / COMMON STOCK
Shares outstanding
55.4M
All holders as of 30 Jun 2025
Q2 2025
Total 13F shares, excl. options
0
Holdings value
$0
Grand Portfolio weight change
0%
Number of holders
0
Number of sells
-3
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Flagship Ventures Fund V, L.P. 52.8% $1.46M 29.2M Noubar Afeyan 29 Dec 2024
Flagship V VentureLabs Rx Fund, L.P. 52.8% 0% $1.46M -$337K 29.2M 0% Noubar Afeyan 03 Feb 2025

Institutional Holders of Omega Therapeutics, Inc. - COMMON STOCK (OMGAQ)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q2 0 $0 -$2.43K 0
2025 Q1 19.6K $2.43K -$35.2M $0.08 3
2024 Q4 47.3M $35.3M -$922K $0.75 50
2024 Q3 48.3M $58.9M -$6.03M $1.22 51
2024 Q2 50.5M $105M -$2.39M $2.07 66
2024 Q1 51.1M $187M +$3.75M $3.65 67
2023 Q4 50.2M $151M +$1.38M $3.01 62
2023 Q3 50.9M $109M -$615K $2.15 56
2023 Q2 51.1M $286M +$4.69M $5.60 58
2023 Q1 50.2M $303M +$25.6M $6.03 54
2022 Q4 16.8M $95.7M +$387K $5.71 46
2022 Q3 42.6M $231M +$907K $5.42 40
2022 Q2 42.5M $161M -$5.64M $3.80 44
2022 Q1 43.5M $272M +$3.78M $6.24 50
2021 Q4 42M $475M +$9.66M $11.33 43
2021 Q3 15M $278M +$278M $18.85 40